We ask you, humbly: don't scroll away.
Hi readers, it seems you use Catholic Online a lot; that's great! It's a little awkward to ask, but we need your help. If you have already donated, we sincerely thank you. We're not salespeople, but we depend on donations averaging $14.76 and fewer than 1% of readers give. If you donate just $5.00, the price of your coffee, Catholic Online School could keep thriving. Thank you.Help Now >
Is the current Ebola strain mutating twice as fast as previous strains?
FREE Catholic Classes
Studies done on some of the early Ebola cases in Sierra Leone reveal the frightening fact that the virus had over 300 genetic mutations as it went from person to person. Even more frighteningly, these changes may make diagnostic tests and experimental treatments now in development less effective.
Highlights
Catholic Online (https://www.catholic.org)
8/29/2014 (9 years ago)
Published in Africa
Keywords: Ebola, Health, Africa, International, Nigeria, Congo, World Health Organization
LOS ANGELES, CA (Catholic Online) - "We found the virus is doing what viruses do. It's mutating," said Pardis Sabeti of Harvard University and the Broad Institute, who led the study of samples from 78 people in Sierra Leone. Each case in the study is of those whose infections could be traced to a faith healer who had claimed a cure, which attracted Ebola patients from Guinea.
As Ebola sweeps through West Africa, every prayer is needed to help those affected.
This study was published in the journal Science, and suggests that the virus is mutating quickly and in ways that make current diagnostic and future vaccines and treatments less effective.
The study comes as the World Health Organization (WHO) said that the epidemic could infect more than 20,000 people, and has the possibility to spread to more countries.
One of the study's authors, Robert Garry of Tulane University, said that the virus is mutating twice as fast as it was in animal hosts. The study shows changes in the glycoprotein, surface proteins that bind the virus to human cells, allowing it to start replicating within a human host. "It's also what your immune system will recognize," he said.
Erica Ollmann Saphire of the Scripps Research Institute in La Jolla, California, has already checked the data to see if it impacts the three antibodies in ZMapp, am experimental drug which has been used to treat Ebola patients in the U.S. and Africa.
"It appears that they do not [affect ZMapp]," said Saphire, who directs a consortium to develop antibody treatments for Ebola and related viruses. But she said that this data "will be critical to seeing if any of the other antibodies in our pool could be affected."
---
'Help Give every Student and Teacher FREE resources for a world-class Moral Catholic Education'
Copyright 2021 - Distributed by Catholic Online